Merck Canada urges Canadians to take action for their lung health with new “Listen Close” campaign
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq fall as megacap tech drags; Iran developments watched
- Oil falls 4% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- China makes small dent in deflation battle as supply-demand imbalance persists
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Merck (MRK) PT Lowered to $129 at Goldman Sachs
February 5, 2025 6:35 AM ESTGoldman Sachs analyst Chris Shibutani lowered the price target on Merck (NYSE: MRK) to $129.00 (from $135.00) while maintaining a Buy rating.
The analyst comments "Amidst a backdrop where MRK delivered strong operational performance across the majority of the company's key franchises, the announcement of 2025 guidance, highlighted by the negative impact of the nettlesome dynamics for... More
